STI Technologies acquired by Quintiles IMS

February 21st, 2017.  Halifax-based STI Technologies was acquired by QuintilesIMS (NYSE: Q -), the world’s largest provider of biopharmaceutical development and commercial outsourcing services for an amount reported by Allnovascotia.com to be about $200 million. Founded in 2001, STI received a $17 million investment from Imperial Capital Group to accelerate the Company’s Canadian market-leading intelligent reimbursement card technology.

Source: BetaKit

For more information, click here!